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Summary 
This study has characterised the transport mechanism(s) for the novel and selective inhibitor 
of inducible nitric oxide synthase (iNOS), GW274150, in murine macrophage J774 cells. 
Transport of GW274150 was saturable (Km = 0.24±0.01 mM and Vmax of 8.5±0.12 pmol. µg 
protein-1 min-1), pH-insensitive and largely Na+-independent. Transport was also susceptible 
to trans-stimulation and was significantly inhibited by a 10-fold excess of L-arginine, L-
lysine, L-leucine, L-methionine, L-glutamine and 6-diazo-5-oxo-L-norleucine but not by 
other amino acids or by N-ethylmaleimide. More importantly, the inhibitions caused by the 
neutral amino acids were critically dependent on Na+. These results strongly implicate system 
y+L in the transport of GW274150. Northern blot analysis confirmed this by revealing the 
presence of transcripts for y+LAT-1 but not y+LAT-2. Thus, taken together, our data show for 
the first time that J774 macrophages express y+LAT-1 transporters and that these carriers 
mediate transport of GW2741500 at least in these cells.  
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Introduction 
Nitric oxide (NO) has emerged as an important mediator of a wide range of physiological and 
pathophysiological functions in mammalian systems (Moncada et al., 1991; Gross & Wolin, 
1995). The precise nature of the responses produced by this diverse molecule appears to 
depend on the amounts and source of production.  Nitric oxide is synthesised by the enzyme 
nitric oxide synthase (NOS) of which there are at least three distinct isoforms: neuronal NOS 
(nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS) (Knowles & Moncada, 1994; 
Alderton et al., 2001). Both nNOS and eNOS are Ca2+-calmodulin-dependent enzymes which 
are constitutively expressed in a variety of tissues and produce short bursts of pico- to 
nanomolar concentrations of NO following agonist stimulation. At these relatively low 
concentrations, NO produced by eNOS may function as a physiological mediator, playing an 
important role in regulating vascular smooth muscle tone, peripheral resistance and thus 
blood pressure (Rees et al., 1989; Vallance et al., 1989). Similarly, NO from nNOS may 
mediate diverse neuronal functions acting, for instance, within the peripheral nervous system 
as a classical neurotransmitter in regulating gastrointestinal motility and regional blood flow 
(Sanders & Ward, 1992).  
 
In contrast to its constitutive isoforms, iNOS is a Ca2+-calmodulin-insensitive enzyme which 
is induced following exposure to several inflammatory stimuli including cytokines and 
bacterial lipopolysaccharide (LPS). Once induced, iNOS produces sustained nano- to 
micromolar concentrations of NO which contribute to the pathogenesis of various 
inflammatory diseases. In this regard, enhanced production of NO by iNOS within the 
vasculature has been implicated in the pathogenesis of septic shock, mediating vascular 
hyporeactivity not only in experimental models (Julou-Schaeffer et al., 1990) but also in 
patients with sepsis (Ochoa et al., 1991; Lorente et al., 1993; Tsuneyoshi et al., 1996). 
Additionally, iNOS derived NO may also play a role in other inflammatory and autoimmune 
disorders including rheumatoid arthritis (McCartney-Francis et al., 1993) and inflammatory 
bowel disease (Yamada et al., 1993).   
 
These pathological actions of NO makes selective targeting of iNOS a key therapeutic 
strategy for the treatment of diseases associated with the over production of NO. 
Considerable effort has indeed been devoted to this area of NO research, resulting in the 
 
 -4- 
production of a vast and expanding list of compounds which inhibit NO synthesis (Babu & 
Griffith, 1998; Hobbs et al., 1999; Alderton et al., 2001). Amongst this growing list is (S)-2-
amino-(1-iminoethylamino)-5-thioheptanoic acid (GW274150), a sulphur-substituted 
acetamidine derivative of L-lysine which shows a high selectivity for iNOS (IC50 ~1.4 µM) 
when compared to either eNOS (IC50 ~ 466 µM) or nNOS (IC50 ~ 145 µM) (Young et al., 
2000). Moreover, GW274150 is effective not only against the isolated enzyme but is also 
highly potent in intact cell systems suggesting that it can be transported into cells to exert its 
effects.  
 
At present very little is known about the mechanisms associated with the uptake of this 
compound into cells. We have therefore carried out experiments examining the entry 
characteristics of GW274150 in an attempt to identify the carrier(s) associated with its 
transport. These studies are essential and important in terms of the potential therapeutic 
utility of GW274150. Moreover, the data obtained has identified a novel entry mechanism for 
iNOS inhibitors which has previously not been described for this class of compounds.  
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Materials and Methods 
 
Cell culture 
The murine monocyte/macrophage cell line J774 was maintained in continuous culture in 
T75 tissue culture flasks in Dulbecco's modified Eagle’s medium (DMEM) supplemented 
with penicillin (100 units ml-1), streptomycin (100 mg ml-1) and 10% foetal bovine serum. 
Cells were harvested by gentle scraping and plated into wells for experimentation or 
passaged every 4 days by dilution of a suspension of the cells 1: 4 in fresh medium.  
 
Measurement of GW274150 transport 
J774 cells were plated at a density of 105 cells per well in 96-well microtiter plates and 
allowed to adhere overnight prior to transport studies which were carried out as described 
previously (Bogle et al., 1992). Briefly, adherent cells were rinsed twice with a modified 
Hepes-buffered Krebs solution (composition (mM): NaCl, 131; KCl, 5.5; MgCl2, 1; CaCl2, 
2.5; NaHCO3, 25; NaH2PO4, 1; D-glucose, 5.5; Hepes, 20; pH 7.4) and uptake was initiated 
by adding Hepes-buffered Krebs (50 µl per well; 37oC) containing [14C]GW274150 (1 µCi 
ml-1) to the monolayers. Incubations were terminated by placing the plates on melting ice and 
rinsing cells three times with 200 µl ice-cold Krebs buffer. 100 µl of the bicinchoninic acid 
protein reagent (Smith et al., 1985) was then added to wells causing rapid lysis of cells. 
Absorbance values were determined at 620 nm on a Multiskan II plate reader after 40 min of 
incubation at room temperature. Values obtained were converted to total protein per well 
using a protein standard curve generated from bovine serum albumin. The amount of 
radioactivity (dpm) in cell lysates was determined by liquid scintillation counting. Uptake 
was then calculated and expressed in units of pmoles µg protein-1 min-1.  
 
Time course and kinetics of GW274150 transport 
The time course of uptake of GW274150 was monitored by incubating cells with 
[14C]GW274150 (100 µM; 1 µCi ml-1) in Hepes-buffered Krebs solution (50µl; 37oC) for 
varying time periods ranging from 30 s to 60 min. Transport was then terminated and total 
[14C]GW274150 accumulated in cells determined as described above. 
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In kinetic experiments cells were incubated for 1 min in either normal Hepes-buffered Krebs 
solution (50µl; 37oC) or Na+-free Krebs solution (see below) containing increasing 
concentrations (0.005 - 1 mM) of [14C]GW274150 (1 µCiml-1). The data obtained was fitted 
using the Michaelis-Menten equation or subjected to Eadie-Hofstee analysis.  
 
Selectivity of GW274150 transport 
Inhibition of GW274150 transport by competitor amino acids was investigated by incubating 
cells with Krebs solution containing 100 µM [14C]GW274150 (1 µCi ml-1) in the absence or 
presence of a 10-fold excess (1 mM) or increasing concentrations of a given inhibitor 
substrate. Parallel inhibition studies were carried out by replacing normal Krebs solution with 
Na+-free Krebs as described below.   
 
pH and Na+-dependency of GW274150 transport 
The dependency of GW274150 uptake on extracellular pH was monitored in Krebs solution 
titrated with 0.1N HCl or NaOH to achieve pH values ranging from pH 8 to pH 5.5. In 
sodium-free experiments, the buffer was modified by replacing NaCl, NaHCO3 and NaH2PO4 
with choline chloride, choline bicarbonate and KH2PO4, respectively. All studies were 
terminated after a 1 min incubation period.   
 
Effects of NEM on GW274150 transport 
Cells were incubated with the sulfhydryl reagent, N-ethylmaleimide (NEM) for 1 min to 30 
min at 22oC. The effects of NEM were negated by adding 10 mM of 2-mercaptoethanol to 
each well and the cells washed before monitoring transport of  [14C]GW274150 (100 µM; 1 
µCiml-1) over 1 min. 
 
Trans-stimulation of GW274150 efflux from [14C]GW274150 loaded J774 cells 
Cells were loaded with [14C]GW274150 (100 µM; 1 µCi ml-1) for 30 min at 37oC in standard 
Krebs buffer. After this period, cells were washed and incubated in fresh buffer containing 1 
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mM of either L-arginine, L-leucine, L-methionine or L-glutamine. Radioactivity in the 
medium and in cell lysates was determined at 5, 10 and 15 min and the efflux values 
expressed as % of radioactivity released from the cells: radioactivity in 
medium/(radioactivity in medium + radioactivity in lysates)*100%.  
 
 
Northern Blot  analysis of y+LAT expression 
 
RNA was prepared from confluent monolayers of J774 cells using RNA STAT-60 
(Biogenesis, Poole, UK) according to the manufacturer’s protocol. The concentration of RNA 
in solution was determined spectrophotometrically and the quality verified by visualization of 
28S and 18S rRNA bands after electrophoresis through a 1% ethidium bromide stained 
agarose gel. For Northern blot analysis, 25 µg of RNA was electrophoresed through a 
formaldehyde-agarose gel, transferred to a nylon membrane (Hybond N+, Amersham) and 
crosslinked by UV irradiation. Probes for y+LAT-1, y+LAT-2 and 18S rRNA control were 
labelled by random-priming using the redi-prime kit from Amersham following the 
manufacturer’s instructions. The y+LAT-1 probe consisted of a fragment containing 
nucleotides 28 to 683 of its published sequence (accession number: AJ012754) and the 
y+LAT-2 probe consisted of a fragment from nucleotides 142 to 563 of the sequence in the 
gene bank (accession number: NM_178798). The 18S ribosomal RNA probe corresponded to 
a fragment encompassing nucleotides 500 to 672 of the rat published sequence (Torczynski et 
al., 1983). Total RNA isolated from mouse kidney was used as a positive control for 
identification of y+LAT1 expression.  
 
After labelling, non-incorporated nucleotides were removed by centrifugation using 
sepharose spin columns (MicroSpinPM G-25, Amersham). Hybridization was carried out 
overnight at 65oC in a hybridisation mix that consisted of 0.25 M Na2HPO4/NaH2PO4 buffer 
(pH 7.2), 1mM EDTA, 20% SDS and the respective denatured probes (20 ng at 109 dpm/µg 
DNA). After hybridization, blots were washed in 2X standard saline citrate buffer (SSC) for 
30 minutes at 65oC followed by a second wash in 0.2X SSC for 30 minutes at 65oC. Blots 
were subsequently exposed to an X-ray film (HyperfilmTM MP, Amersham Pharmacia 
Biotech) with an intensifying screen at -80°C. The relative intensities of the bands produced 
were determined by densitometry.  
 
 -8- 
 
Materials 
All reagents for cell culture except foetal calf serum (Sigma) were from Gibco (Paisley, 
U.K.). Other chemicals were from Sigma or BDH and of the highest grade obtainable. 
Unlabelled and radioactive L-[14C]GW274150 (54.3 mCi/mmol) were obtained from 
GlaxoSmithKline (Stevenage, UK) and the 18S ribosomal RNA probe was kindly provided 
by Dr A. Felipe (University of Barcelona, Spain). 
 
Statistics 
All values are means ± s.e.m. of at least three separate experiments with six replicates per 
experiment. Statistical analyses were performed by one-way ANOVA followed by the 
Dunnetts multiple comparison test with the overall confidence levels set at 95%. 
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Results 
Time course and Kinetics of GW274150 transport 
Time course experiments revealed that transport of L-[14C]GW271450 (100 µM; 1 µCi ml-1) 
into cells was rapid and linear for up to 3 min,  saturating thereafter and reaching a plateau 
after 20 min of incubation (Fig. 1). On the basis of these observations, all subsequent 
experiments were carried out over a 1 min period to ensure that transport was measured at 
initial rates.  
 
Kinetic analysis revealed that transport of GW274150 occurs via a saturable high affinity 
carrier with a Michaelis constant (Km) of 0.24±0.01 mM and a maximal transport rate 
velocity (Vmax) of 8.5±0.12 pmol. µg protein-1 min-1 (Fig. 2). Eadie-Hofstee transformation of 
the data (inset in Fig. 2) produced a single linear regression line compatible with the 
operation of a single saturable system or systems with indistinguishable functional 
characteristics. When repeated in the absence of Na+, transport of GW274150 was 
indistinguishable to that observed in normal Krebs buffer in that both the Vmax (8.2±0.11 
pmol. µg protein-1 min-1) and Km (0.27±0.01  mM) remained virtually unaltered.  
 
pH and Na+-dependency of GW274150 transport 
The effects of pH on [14C]GW274150 transport was examined in Krebs buffer with varying 
pH values ranging from pH 8 to pH 6.0. The results in Table 1 show that uptake was largely 
pH insensitive.  
 
In addition to its pH insensitivity, transport of GW274150 was also largely Na+-independent 
since rates measured in Na+-free Krebs solution were only marginally lower than those 
determined in the presence of Na+ (Table 1).   
 
Selectivity of GW274150 transport 
Cross inhibition studies were carried out in the presence and absence of Na+ to evaluate the 
substrate specificity of the transporter(s) associated with GW274150 uptake by J774 cells. 
Under these conditions, transport of [14C]GW274150 was not affected by a 10-fold  excess of 
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either 2-methylaminoisobutyric acid (MeAIB), L-alanine, L-valine or ß-2-amino-bicyclo-
(2,2,1)-heptane-2-carboxylic acid (BCH) but was inhibited by 64±1 %, 60±2 %, 54±2 %, 
50±2 %, 45±2 % and 43±2 in the presence of L-arginine, L-lysine, L-leucine, L-methionine, 
L-glutamine and 6-diazo-5-oxo-L-norleucine (DON) respectively. These inhibitions, with the 
exception of that caused by L-arginine and L-lysine, were critically dependent on 
extracellular Na+ and completely reversed when extracellular Na+ was replaced with choline 
(Fig. 3).  
 
Further analysis using selected amino acids show that transport rates for GW274150 were 
inhibited in a concentration-dependent manner by L-arginine, L-leucine, L-methionine and L-
glutamine with respective ki values of 0.04 mM, 0.06 mM, 0.07 mM and 0.13 mM.  
 
Effects of NEM on GW274150 transport 
The profile of inhibition reported above strongly suggests that transport of GW274150 may 
occur via a system or systems with characteristics similar to those of system y+ and/or other 
cationic amino acid transporters such as y+L/y+LATs (see Deves & Boyd, 1998; Palacin et 
al., 1998 for reviews). To further characterise the transporter(s) associated with uptake of 
GW274150, additional studies were therefore carried out in cells pre-treated with NEM 
which apparently discriminates between system y+ and y+L by inhibiting the former (Deves et 
al., 1993). In these studies, NEM (0.2 mM) failed to cause any significant inhibition in 
transport of GW274150 when exposed to cells for short periods of 1 min - 5 min (data not 
shown). Longer incubations reduced transport of L-arginine but these effects were 
accompanied by a marked decrease in cell number and total cell protein (~16 % after 10 min 
and ~37 % after 30 min pre-incubations) which may be indicative of a non-specific cytotoxic 
action of NEM.  
 
Trans-stimulation of GW274150 transport 
Efflux of radioactivity from J774 cells preloaded with [14C]GW274150 was determined over 
a time period in the absence (control) and presence of 1 mM of either L-arginine, L-leucine 
or L-glutamine. As shown in Fig. 4, efflux of [14C]GW274150 from control cells was low and 
showed no significant change over time. In contrast, the presence of either L-arginine, L-
 
 -11- 
leucine or L-glutamine in the incubation buffer resulted in a significant and time-dependent 
release of [14C]GW274150 into the medium. Interestingly, L-glutamine which was relatively 
weaker in inhibiting influx of GW274150 (ki = 0.13 mM vs  0.04 mM and 0.06 mM for L-
arginine and L-leucine respectively) was also less potent in inducing efflux when compared 
to either L-leucine or L-arginine, indicating that this amino acid may be a relatively weaker 
substrate for the GW274150 transporter.  
 
Northern blot analysis of y+LAT expression in J774 cells 
To confirm whether J774 macrophages express known system y+L associated genes, we 
probed for the expression of y+LAT-1 and y+LAT-2 mRNA by Northern blot analysis using 
total RNA isolated from these cells. The results obtained revealed the expression of 
transcripts for y+LAT-1 (Fig 5) but not for y+LAT-2 (data not shown) in control non-
activated cells. These findings are the first, to our knowledge, to report the expression of 
y+LAT-1 in J774 macrophages.   
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Discussion 
The characteristics of the transport of GW274150 by J774 macrophages was studied to gain 
an insight into the mechanisms associated with the uptake of this potent and highly selective 
iNOS inhibitor into control non-activated cells.  The results obtained show that GW274150 
can cross cell membranes in a time-dependent manner and that the uptake process is largely 
pH and Na+ insensitive. Kinetic analysis revealed a saturable transport system with a 
relatively high affinity but low capacity. In addition, the transporter was sensitive to trans-
stimulation but only marginally altered by NEM which was found to be highly cytotoxic, 
reducing total cell protein significantly even after short incubations.  
 
To further unravel the nature of the transporter(s) involved with the uptake of GW274150, 
inhibition analysis was carried out using system specific substrates in cross-inhibition 
studies. The data from these experiments show that uptake can be modified Na+-
independently by cationic amino acids and Na+-dependently by select neutral amino acids 
which were also able to induce [14C]GW274150 efflux from cells preloaded with this 
compound. These findings therefore indicate that transport of GW274150 occurs via a system 
or systems capable of interacting with both basic and neutral amino acids and thus eliminate 
other transporters that show selectivity for either neutral or cationic amino acids alone. One 
such system is the amino acid transporter system A, which is a Na+-dependent and pH-
sensitive carrier of small neutral amino acids (Christensen, 1990; McGivan & Pastor-
Anglada, 1994). Conclusive evidence that supports a lack of involvement of this transporter 
in the uptake of GW274150 is the observation that MeAIB, a model substrate for system A 
(Christensen, 1965), failed to modify initial rates of GW274150 transport even when used at 
a 10-fold excess. Furthermore, system A generally shows weak responses to trans-
stimulation, a key feature of the transport of GW274150 in J774 macrophages. Additionally, 
L-valine and L-alanine, known substrates for this carrier and indeed the ASC system 
(Christensen et al., 1967), were also without effect, confirming that neither system A nor 
ASC may be involved in the transport of GW274150, at least, in J774 macrophages.  
 
The other system for which there is strong evidence against its involvement in the uptake 
process of GW274150 is the Na+-insensitive system L, which shows high specificity for 
branched-chain and aromatic amino acids (Oxender & Christensen, 1963; Christensen, 1990), 
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and utilises the non-metabolisable bicyclic BCH analogue as a system specific substrate 
(Christensen et al., 1969). Thus, since BCH was without effect in our studies, it is reasonable 
to conclude that this pathway does not contribute to the uptake of GW274150 to any 
significant extent. Interestingly, other known system L substrates such as L-leucine and L-
methionine, caused marked inhibition of GW274150 transport. These effects were however 
critically dependent on the presence of Na+ which is uncharacteristic of the L transporter 
whose interaction with both these amino acids is largely Na+-independent (Oxender & 
Christensen, 1963; Christensen, 1990). Thus, despite the marked inhibitions caused by L-
leucine and L-methionine, the Na+-dependency of their actions together with the lack of 
inhibition by BCH strongly argues against system L being utilised by GW274150 for entry 
into cells.  
 
Similarly, the inhibitions caused by L-glutamine, a system N substrate (Kilberg et al., 1980), 
and DON, a model substrate for system N (Goldstein, 1975) do not confirm that this pathway 
is indeed involved in the uptake of GW274150 into J774 macrophages. In this case the 
argument against is the fact that system N is Na+-dependent, pH-sensitive and does not 
interact with either cationic amino acids or leucine (Kilberg et al., 1980). Transport of 
GW274150 on the other hand, was largely Na+- and pH-insensitive and was also significantly 
blocked by both L-arginine and L-lysine and by L-leucine. It is worth noting that L-
glutamine, as with L-leucine and L-methionine, is capable of interacting with other amino 
acid transporters distinct from its recognised carrier (system N) and do so in the absence or 
presence of Na+ as a surrogate cation. This mostly occurs through a family of broad-scope 
carriers capable of transporting both neutral and basic amino acids with relatively high 
affinity. 
 
At present there are at least three distinct broad-scope amino acid transporters. These 
systems, identified as Bo,+, bo,+, and y+L share some common similarities in their 
characteristics but can also be discriminated on the basis of their requirement for Na+ in 
transporting amino acids (Deves & Boyd, 1998; Palacin et al., 1998). For instance, Bo,+ is 
defined by Na+-dependent transport of both neutral and cationic amino acids and also by its 
ability to accept BCH and interact with relatively small amino acids such as valine (Van 
Winkle et al., 1985). In contrast, bo,+ is Na+-independent and capable of transporting both 
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neutral and basic amino acids with comparatively high affinity in the absence of Na+ (Van 
Winkle et al., 1988; Bertran et al., 1992; Wells & Hediger, 1992). In our studies transport of 
GW274150 was largely Na+-independent and significantly attenuated by both cationic and 
neutral amino acids with the inhibition caused by the latter being critically dependent on the 
presence of Na+ and that caused by the former persisting even on removal of Na+ from the 
assay buffer. Thus, on the basis of these findings, it is highly unlikely that either Bo,+ or bo,+ 
play any significant role in transporting GW274150 into J774 cells. The system that would 
carry out this process would be one that relies on Na+ for transport of neutral but not of basic 
amino acids. This feature is in fact characteristic of the classical broad-scope y+L transporter 
(Deves et al., 1992; Deves et al., 1998) which recognises neutral and basic amino acids with 
high affinity but shows differential effects towards these substrates by its requirement for Na+ 
in interacting with the neutral but not with the cationic amino acids (Deves et al., 1992; 
Angelo & Deves, 1994; Fei et al., 1995; Deves et al., 1998). Moreover, system y+L does not 
recognise BCH (Fei et al., 1995), discriminating it from the L transporter and further 
strengthening its role in the transport of GW274150, at least in J774 macrophages. 
 
In addition to y+L it is worth considering whether transport of GW274150 may be facilitated 
by the classical cationic amino acid transporter y+ (White, 1985; Deves & Boyd, 1998; 
Palacin et al., 1998). This transport system is know to be expressed in J774 macrophages 
(Bogle et al., 1992; Baydoun  et al., 1994) and the marked inhibition by both L-arginine and 
L-lysine together with the Na+-independency of this inhibition would strongly implicate this 
system as a key target for the entry of GW274150 into cells. System y+ however has only 
weak affinity for some neutral amino acids such as homoserine (Wang et al., 1991) and does 
not appear to facilitate uptake of either leucine, glutamine or methionine (Kim et al., 1991) 
which we have shown to be able to cause marked inhibitions of the transport of GW274150 
in our system. Also of significance is the additional finding with DON which does not 
interact with system y+ in J774 macrophages (Baydoun et al., 1994) but attenuated 
GW274150 uptake quite markedly in the same cells. The rational deduction from these data 
therefore is that system y+, although potentially expressed, may not be the transporter for 
GW274150 in control J774 cells. This is interesting because GW274150 is an acetamidine 
derivative of hetero-substituted lysine (Young et al., 2000) and would be expected to interact 
with system y+. The fact that this was not the case raises the question of the relative 
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expression levels of the system y+ protein in our cells. We cannot rule out that this 
transporter, although present, may be expressed in relatively low levels that may not be 
sufficient to make a major contribution to the total uptake of GW274150. Additional studies 
looking at the expression levels of CAT-1 expression for instance may help shed more light 
on this. Such studies are however limited by the lack of readily available selective antibodies 
for these proteins.  
 
Despite the argument raised above, it is clear that system y+ may not be involved in the 
transport of GW274150 under our current experimental conditions. Further evidence in 
support of this notion was obtained in studies with NEM which apparently discriminates 
between systems y+L and y+ by inhibiting the activity of the latter (Deves et al., 1993). This 
compound however failed to cause any discernible change in the transport of GW274159 
when used under non-cytotoxic conditions (short incubations) at concentrations (0.2 mM) 
shown to abolish y+ activity in other systems (Deves et al., 1993; Patel et al., 1996; Peter et 
al., 1999; Dall_Asta et al., 2000). Although greater inhibitions were observed with prolonged 
incubations (> 10 min) these effects were characterised by a conspicuous decrease in cell 
number and total cell protein, indicative of a non-selective cytotoxic action by NEM. These 
responses should therefore be interpreted with caution and not ascribed to the expected 
inactivation of the y+ transporter defined in other systems.     
 
All the data discussed thus far give a strong indication that y+L rather than systems A, L, N or 
y+ may be the relevant transporter for GW274150 in J774 macrophages. We cannot however 
rule out that a fraction of GW274150 transport may occur through low affinity routes which 
are yet to be identified. This supposition is based on the fact that none of the inhibitor amino 
acids used completely suppressed GW274150 transport into cells. In each case there was a 
small component of entry which was not susceptible to inhibition even in the presence of a 
large excess of competitor substrate.  
 
Although the indication is that a transporter similar to y+L may be involved with uptake of 
GW274150, it is not clear whether this is the classical y+L carrier identified in erythrocytes 
(Deves et al., 1992). The affinity of the latter for amino acids seems somewhat higher (Km ~ 
12 µM) than that inferred in this study for the same amino acids from inhibition studies (Ki 
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40-130 µM). y+L is however emerging as a family of distinct heterodimeric proteins which, 
although characterised by their dependency on Na+ for transport of neutral amino acids and 
Na+-independency for interaction with basic amino acids, may be distinguished by their 
tissue distribution and by their relative affinity for different substrates. At present there are at 
least two distinct y+L transporters which consist of the heavy chain 4F2hc glycoprotein and 
one of two light chains designated as y+LAT-1 and y+LAT-2 (Torrents et al., 1998; Pfeiffer et 
al., 1999; Broer et al., 2000). Whether these novel proteins are associated with the reported 
y+L activity in erythrocytes remains to be established. However, both y+LAT-1 and y+LAT-2 
are expressed in most tissues with levels of the former being most apparent in the intestine, 
kidney, lung and leucocytes(Torrents et al., 1998; Pfeiffer et al., 1999) whilst y+LAT-2 
appears to be more prominent in the brain, heart, testis, small intestine and parotids (Broer et 
al., 2000).  
 
At the functional level, y+LAT-1 shows a much higher affinity for neutral amino acids (Km 
~20-30 µM vs Km of ~ 340 µM for L-arginine (Pfeiffer et al., 1999)) while y+LAT-2 shows a 
marginal preference for cationic substrates (Km for L-arginine ~120 µM vs 236-295 µM for 
leucine and glutamine respectively (Broer et al., 2000)). Either of these carriers may be 
involved with the transport of GW274150 in J774 macrophages. However, although there are 
reports of system y+L activity in rabbit (Racké et al., 1998) and rat alveolar macrophages 
(Messeri Dreißig et al., 2000) and y+LAT-1 expression has been shown in human monocytes 
(Rotoli et al., 2004) there is no published literature on the expression or function of these 
proteins in J774 macrophages. We have therefore extended our studies by examining whether 
transcripts for y+LAT-1 and/or y+LAT-2 are expressed in our cell system by Northern blot 
analysis of total RNA isolated from control cells. The data obtained revealed basal expression 
of y+LAT-1 mRNA but not of y+LAT-2, suggesting that the former may be the carrier for 
GW274150 in J774 macrophages. 
 
 In summary data has been produced showing that GW274150 is transported by J774 
macrophages via a system which is characteristically similar to the classical system y+L and 
in particular to the newly identified y+LAT-1 transporter. This conclusion is based on several 
observations including the detection of transcripts for y+LAT-1 in control cells. Moreover, 
the characteristic Na+-dependent and Na+-independent inhibitions caused by neutral and basic 
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amino acids respectively, and the insensitivity of the system to pH and NEM together with 
the trans-stimulation of GW274150 efflux by both neutral and cationic amino acids are 
compatible with the involvement of system y+L in facilitating transport of GW274150, at 
least in J774 macrophages. To our knowledge, this is also the first report to demonstrate the 
expression of y+LAT-1 in J774 macrophages and, in agreement with a recent report by Rotoli 
et al. (2005), suggests a critical role for these carriers in the transport of NOS inhibitors 
which, previously, may have been ascribed to the CATs (Baydoun and Mann, 1994).  Should 
y+LAT-1 be sensitive to induction by inflammatory mediators the resulting upregulation in its 
expression may provide a mechanism for enhancing the delivery of GW274150 into cells 
expressing iNOS.  This has indeed been shown for transport of other NOS inhibitors through 
system y+ (Baydoun and Mann, 1994) and could have potential therapeutic benefits in 
enhancing the potency of GW274150 against iNOS.  
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Table 1. Effects of Na+ and pH on GW274150 transport in J774 macrophages.  
 
 
 
Condition    Transport  Rate 
         (pmoles µg protein-1 min-1) 
 
Na+-dependency 
 
Control (+Na+)   2.1 ± 0.13 
-Na+     1.7 ± 0.07 
 
 
pH-dependency 
 
pH 8.0     1.92 ± 0.02 
pH 7.4 (Control)   2.05 ± 0.09 
pH 7.0     1.99 ± 0.04 
pH 6.5     1.92 ± 0.05 
pH 6.0     1.84 ± 0.01 
 
 
 
Transport of 100 µM GW274150 was measured over 1 min in the presence (normal Krebs 
solution) or absence of Na+ and at varying pH values ranging from pH 8-pH 6.0. Values are 
the means ± s.e.m. of three different experiments with six replicates in each. 
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Figure 1 
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Figure 2   
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Figure 4 
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Figure 5 
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FIGURE LEGENDS 
 
Fig. 1 Time course of GW274150 transport in control J774 macrophages.  
Uptake of GW274150 (100 µM, 1 µCi ml-1) was monitored from 30 s to 60 min in normal 
Krebs buffer as described in methods. The inset shows linear uptake for up to 3 min.  Values 
are the mean ± s.e.m. of 6 replicate measurements in 3 separate experiments. 
 
Fig. 2 Kinetics of GW274150 transport in control J774 macrophages. 
Transport of GW274150 (25-1000 µM, 1 µCi ml-1) was monitored over a 1 min period in 
control cells as described in methods. Values are the mean ± s.e.m. of 6 replicate 
measurements in 3 separate experiments. The inset shows an Eadie-Hofstee plot of saturable 
transport.  
 
Fig. 3 Specificity of GW274150 transport in control J774 macrophages.  
Inhibition of GW274150 (100 µM, 1 µCi ml-1) transport by a 1 mM excess of competing 
substrates was measured in the presence (solid bars) and absence (hatched bars) of Na+ in 
control non-activated cells. Data are expressed as a percentage of the transport rate measured 
in the absence of an inhibitor. Abbreviations denote standard amino acid nomenclature. 
Values denote the mean ± s.e.m. of 6 replicate measurements in 3 experiments. 
 
Fig. 4 Trans-stimulation of GW274150 efflux in control J774 macrophages. 
Confluent monolayers of J774 cells were preloaded with GW274150 (100 µM; 1µCiml-1) for 
30 min at 37oC in standard Krebs buffer. Efflux of [14C] was determined over a time period in 
the absence (open bars) and presence of 1 mM of either L-arginine (solid bars), L-leucine 
(hatched bars) or L-glutamine (spotted bars) as described in methods. Radioactivity in the 
medium and in cell lysates were determined and the values expressed as % of radioactivity: 
radioactivity in medium/(radioactivity in medium + radioactivity in lysates)*100%. Data are 
the mean ± s.e.m. of 6 replicate measurements in 3 experiments. 
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Fig. 5  Northern blot analysis of y+LAT-1 mRNA expression in J774 macrophages.  
Total RNA from J774 cells or mouse kidney (25 µg) was separated on a 1% agarose gel, 
blotted to a nylon membrane, hybridized to a 32P labelled probe and developed as described 
in the methods. The blot shown is representative of 3 independent analyses and 5 
independent RNA preparations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
